← European Medicine Shortage Tracker · all medicines

Natrium naproxenat, sumatriptan succinat shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Natrium naproxenat, sumatriptan succinat currently has availability issues reported in 1 European register: Austria.

Shortage  ATC N02CC51 · also listed as: NATRIUM NAPROXENAT, SUMATRIPTAN SUCCINAT · data refreshed 6 November 2026

Key facts

As of 6 November 2026, 1 of the 10 tracked registers list current availability issues for Natrium naproxenat, sumatriptan succinat, covering 1 affected product presentation. The longest-running open report was filed in Austria on 2026-05-27 and has now been open for about 6 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-12-01; the earliest is 2027-12-01. In the WHO ATC classification, Natrium naproxenat, sumatriptan succinat is coded N02CC51 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaShortage
Sumanet 85 mg/500 mg Filmtabletten (PZN 5537615)
2026-05-272027-12-01Kapazitätsengpässe bei der Herstellungregister ↗

Full report history (1 register entry)

Every individual register entry for Natrium naproxenat, sumatriptan succinat in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇦🇹 ATSumanet 85 mg/500 mg Filmtabletten (PZN 5537615)Shortage2026-05-272027-12-01Kapazitätsengpässe bei der Herstellung

Frequently asked

Is Natrium naproxenat, sumatriptan succinat currently in shortage in Europe?

Yes. As of 6 November 2026, availability issues are reported in: Austria. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Natrium naproxenat, sumatriptan succinat shortage expected to end?

Agency prognoses on file range from 2027-12-01 to 2027-12-01. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Where does this Natrium naproxenat, sumatriptan succinat availability data come from?

Directly from the official medicines-agency register that lists Natrium naproxenat, sumatriptan succinat: BASG (Austria). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Natrium naproxenat, sumatriptan succinat — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/natrium-naproxenat-sumatriptan-succinat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Natrium naproxenat, sumatriptan succinat availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/natrium-naproxenat-sumatriptan-succinat/">Natrium naproxenat, sumatriptan succinat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Natrium naproxenat, sumatriptan succinat: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 6 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.